health
January 17, 2026
Top US court to review suit against German chemicals giant
The US Supreme Court has said it will review a $1.25mn case against German chemicals giant Bayer related to its Roundup herbicide
TL;DR
- The US Supreme Court will hear Bayer's appeal in a Roundup cancer lawsuit.
- A man was awarded $1.25 million, claiming Roundup caused his blood cancer.
- The case hinges on whether companies are liable under state laws for carcinogen warnings when complying with EPA label requirements.
- Bayer argues the EPA has determined glyphosate is not likely carcinogenic and approved Roundup labels without warnings.
- Bayer acquired Monsanto, the original maker of Roundup, in 2018.
- Bayer has faced thousands of similar lawsuits and set aside over $10 billion for potential damages.
- The World Health Organization previously classified glyphosate as "probably" carcinogenic.
Continue reading the original article